Back

The Spliceosome Scaffold Component BCAS2 Promotes Pancreatic Cancer Progression through Weak 5 Splice Site Dependent Splicing Regulation

Wan, L.; Wang, M.; Ishigami, Y.; Kral, A. J.; Lin, K.-T.; Merrill, J. R.; Lyons, S. K.; Krainer, A. R.

2026-10-07 cancer biology
10.64898/2026.10.06.757127 bioRxiv
Show abstract

Pancreatic ductal adenocarcinoma (PDAC) remains one of the deadliest malignancies. Dysregulated RNA splicing has emerged as a critical mechanism contributing to PDAC progression. However, whether structural components of the spliceosome regulate oncogenic alternative splicing was not known. Here, we identify the nineteen complex (NTC) component BCAS2/SPF27 as a critical regulator of PDAC progression. Elevated expression of BCAS2 in PDAC is associated with poor patient outcomes. Transcriptomic analyses revealed that BCAS2 specifically regulates alternative exons with weak splice sites. In particular, BCAS2 promotes SOS1 exon 21 inclusion and consequently RAC-signaling activation. Furthermore, splice-switching antisense oligonucleotide (ASO) mediated skipping of SOS1 exon 21 suppressed PDAC proliferation and migration. Our findings uncover a role of BCAS2 in the regulation of weak splice site usage and identify the BCAS2/SOS1/RAC signaling axis as a potential therapeutic vulnerability in pancreatic cancer.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

1
Oncogene
○ 85 papers in training set
Top 0.1%
11.7%
Similar papers in this journal
2
Nature Communications
○ 5641 papers in training set
Top 19%
9.6%
Similar papers in this journal
3
Cancer Research
● 130 papers in training set
Top 0.4%
6.6%
Similar papers in this journal
4
Cell Reports
○ 1498 papers in training set
Top 5%
6.6%
Similar papers in this journal
5
Molecular and Cellular Biology
○ 47 papers in training set
Top 0.1%
5.4%
Similar papers in this journal
6
Proceedings of the National Academy of Sciences
● 2444 papers in training set
Top 11%
4.8%
7
Nucleic Acids Research
◐ 1281 papers in training set
Top 4%
4.3%
8
Cell Death & Disease
147 papers in training set
Top 0.6%
4.1%
50% of probability mass above
9
eLife
● 5828 papers in training set
Top 31%
4.0%
10
Gastroenterology
○ 42 papers in training set
Top 0.3%
3.2%
11
Molecular Cancer Research
● 49 papers in training set
Top 0.5%
2.4%
12
Molecular Cancer
○ 16 papers in training set
Top 0.1%
2.1%
13
Gut
● 40 papers in training set
Top 0.4%
2.1%
14
Nature Genetics
○ 286 papers in training set
Top 3%
1.9%
15
Science Advances
● 1243 papers in training set
Top 19%
1.9%
16
Communications Biology
○ 993 papers in training set
Top 19%
1.3%
17
Scientific Reports
○ 3612 papers in training set
Top 65%
1.1%
18
BMC Cancer
○ 67 papers in training set
Top 2%
1.0%
19
Cell Death Discovery
○ 58 papers in training set
Top 1%
0.8%
20
Journal of Biological Chemistry
○ 690 papers in training set
Top 10%
0.8%
21
Cancer Discovery
● 66 papers in training set
Top 2%
0.8%
22
Cell Communication and Signaling
○ 51 papers in training set
Top 1%
0.8%
23
Theranostics
● 37 papers in training set
Top 1%
0.8%
24
Cancer Letters
○ 35 papers in training set
Top 1%
0.8%
25
Cancers
○ 213 papers in training set
Top 5%
0.6%
26
EMBO Molecular Medicine
○ 95 papers in training set
Top 3%
0.6%
27
JCI Insight
● 277 papers in training set
Top 9%
0.6%
28
Cellular and Molecular Gastroenterology and Hepatology
○ 46 papers in training set
Top 1%
0.6%
29
Advanced Science
○ 286 papers in training set
Top 12%
0.6%
30
Journal of Experimental Medicine
● 119 papers in training set
Top 4%
0.6%

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.